Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : John Pitera's Market Laboratory -- Ignore unavailable to you. Want to Upgrade?

To: John Pitera who wrote (1080)	4/15/2000 9:50:00 PM
From: Original Mad Dog	Read Replies (1) \| Respond to of 33421

John, You commented on another thread: For example the Major Pharms. have probably bottomed. CSCO, SUNW , ORCL are in the process. CDNW, TSCM, KOOP....... cashing burning heaven. -g- Where do the following two groups fit into that classification scheme, in your opinion? 1. Major Biotechs (AMGN, BGEN, etc.) 2. B2B's (CMRC, ARBA, VERT, CLRS). CLRS in particular seems to have reached a ridiculous low. It's at 31 bucks a share, and they just raised -- I don't know exactly, maybe ten to fifteen bucks a share -- in a secondary priced at 115 (great timing IMO). While their plan was to burn that cash to conquer the great New Economy B2B market, my guess is that they will be spending it more methodically and wisely out of fear that the capital spigots are now closed. Look like a good entry point to you, or are they in the "cash burning heaven" category? TIA, MAD DOG